TC Biopharm

News

Scotland’s TCB inks CAR-T deal with Japan’s NIPRO

News

Discovery Park Technology Fund invests in pioneering clinical development company, TC BioPharm (TCB) providing a launchpad for clinical trials of new treatments for cancer and viral infections